Infection of the CNS with the SARS-CoV-2 can occur via different routes and results in para-
or post-infectious manifestations with a variety of neurological symptoms. In patients with …

At the level of in vitro drug screening, the development of a phenotypic analysis system with
high-content screening at the core provides a strong platform to support high-throughput …

Various neurological symptoms have been associated to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection including headache, fever, anosmia, ageusia, but …

Since the global outbreak of SARS-CoV-2 (COVID-19), infections of diverse human organs
along with multiple symptoms continue to be reported. However, the susceptibility of the …

The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since
2020. Links between the newly discovered viral infection and the pathogenesis of …

Several studies have pointed to retinal involvement in COVID-19, yet many questions
remain regarding the ability of SARS-CoV-2 to infect and replicate in retinal cells and its …

Transgenic mice expressing human angiotensin-converting enzyme 2 under the cytokeratin
18 promoter (K18-hACE2) have been extensively used to investigate the pathogenesis and …

Highlights•Existing models for drug discovery and development against glioblastoma
multiforme (GBM) have limitations.•We review advances in 3D systems that promise more …

A highly contagious virus, severe acute respiratory syndrome coronavirus 2, caused the
coronavirus disease 19 (COVID-19) pandemic (SARS-CoV-2). SARS-CoV-2 genetic …

The SARS-CoV-2 virus, first reported in December 2019 in China, is the causative agent of
the current COVID-19 pandemic that, at the time of writing (1 November 2020) has infected …